Assessing the Effect of Hormonal Contraceptives on Oxidative Stress and Lipid Metabolism in Reproductive Age Women
Hormonal Contraceptives and Oxidative Stress
DOI:
https://doi.org/10.54393/pjhs.v6i7.3319Keywords:
Hormonal Contraceptives, Oxidative Stress, Lipid Metabolism, Reproductive Age WomenAbstract
Women of reproductive age frequently use hormonal contraceptives for family planning and regulating menstrual cycles. There is growing apprehension, however, regarding the potential long-term metabolic and cardiovascular effects of these contraceptives due to their impact on oxidative stress and lipid metabolism. Objective: To assess the impact of hormonal contraceptive use on oxidative stress markers and lipid profile parameters in reproductive-age women. Methods: This comparative cross-sectional study encompassed 150 women aged 18 to 40 years, evenly split into users and non-users of hormonal contraceptives. From each participant, blood samples were drawn to assess oxidative stress Markers Malondialdehyde (MDA), Total Antioxidant Capacity (TAC), Superoxide Dismutase (SOD), catalase, Glutathione Peroxidase (GPx), as well as lipid profile parameters such as total cholesterol, triglycerides, LDL-C, HDL-C, and the LDL/HDL ratio. For the analysis, appropriate parametric and non-parametric tests were applied for the statistical comparisons. Results: Hormonal contraceptive users had significantly higher MDA levels and reduced TAC, SOD, GPx, and catalase activity, indicating elevated oxidative stress and impaired antioxidant defenses (p < 0.001). Lipid profile analysis revealed significantly increased total cholesterol, triglycerides, and LDL-C, along with reduced HDL-C and elevated LDL/HDL ratios among users compared to non-users (p < 0.001). Conclusions: Hormonal contraceptive use in reproductive-age women is associated with increased oxidative stress and an unfavorable lipid profile. These biochemical alterations may raise the risk of cardiovascular complications with long-term use. Regular monitoring and preventive strategies, including lifestyle counseling and antioxidant support, may help mitigate these risks.
References
Akova B, SuÈrmen-GuÈr E, GuÈr H, Dirican M, SarandoÈl E, Küçükoglu S. Exercise-induced oxidative stress and muscle performance in healthy women: role of vitamin E supplementation and endogenous oestradiol. European Journal of Applied Physiology. 2001 Feb; 84(1): 141-7. doi: 10.1007/s004210000331.
Cauci S, Xodo S, Buligan C, Colaninno C, Barbina M, Barbina G et al. Oxidative stress is increased in combined oral contraceptives users and is positively associated with high-sensitivity C-reactive protein. Molecules. 2021 Feb; 26(4): 1070. doi: 10.3390/molecules26041070.
Song X, Chen W, Peng S, Zhong Y, Lin B, Zhang G et al. Effects of pre-conception hormonal medication on steroids and lipidomics in newborns of mothers with PCOS. Reproductive BioMedicine Online. 2025 May: 105044. doi: 10.1016/j.rbmo.2025.105044.
D'Souza AC, Wageh M, Williams JS, Colenso-Semple LM, McCarthy DG, McKay AK et al. Menstrual cycle hormones and oral contraceptives: a multimethod systems physiology-based review of their impact on key aspects of female physiology. Journal of Applied Physiology. 2023 Nov. doi: 10.1152/japplphysiol.00346.2023.
Gold JI, Gold NB, DeLeon DD, Ganetzky R. Contraceptive use in women with inherited metabolic disorders: a retrospective study and literature review. Orphanet Journal of Rare Diseases. 2022 Feb; 17(1): 41. doi: 10.1186/s13023-022-02188-x.
Zeber-Lubecka N, Ciebiera M, Hennig EE. Polycystic ovary syndrome and oxidative stress-from bench to bedside. International Journal of Molecular Sciences. 2023 Sep; 24(18): 14126. doi: 10.3390/ijms241814126.
He J, Deng R, Wei Y, Zhang S, Su M, Tang M et al. Efficacy of antioxidant supplementation in improving endocrine, hormonal, inflammatory, and metabolic statuses of PCOS: a meta-analysis and systematic review. Food & Function. 2024 Jan; 15(4): 1779-802. doi: 10.1039/D3FO02824K.
Shenta AA, Al-Maliki AD, Abou-Turab MK. Evaluation of lipid profile, malondialdehyde, hemoglobin and ferritin in Iraqi women with polycystic ovarian syndrome. European Journal of Clinical and Experimental Medicine. 2025 Jun; 23(2): 378-385. doi: 10.15584/ejcem.2025.2.14.
Lew LA. The Impact of the Menstrual Cycle and Hormonal Contraceptives on Cardiovascular Function in Premenopausal Females (Doctoral dissertation, Queen's University (Canada)). 2024 Sep.
Kobayashi H and Imanaka S. Exploring potential pathways from oxidative stress to ovarian aging. Journal of Obstetrics and Gynaecology Research. 2025 Jan; 51(1): e16166. doi: 10.1111/jog.16166.
Kantarama E. Effect of Depo Medroxyprogesterone Acetate (Dmpa) Injectable Contraceptive on Cardiometabolic Risk Profile among Women of Reproductive Age in Kigali, Rwanda (Doctoral dissertation, University of Rwanda). 2023 Jun.
Cabre HE and Moore SR. The role of female sex hormones and oral combined contraceptives in metabolic adaptations. Journal of Physiology. 2023 Apr; 601(7). doi: 10.1113/JP284316.
Sultan HH, Teimourpour A, Majidi Z, Nabatchian F. Impact of Intermediate-term Oral Contraceptive Use on Oxidative Stress, Lipid Profile, and Liver Function in Iraqi Women: A Comprehensive Biochemical Assessment. Exploratory Research and Hypothesis in Medicine. 2025 Mar; 10(1): 25-35. doi: 10.14218/ERHM.2024.00035.
Turki A, Ayalew A, Mossie A, Mitiku S. Effects of hormonal contraceptives on lipid profile among women attending family planning unit in Goba Town Public Health Facilities, Bale, Southeast Ethiopia: a comparative cross-sectional study. Reproductive Health. 2023 Dec; 20(1): 185. doi: 10.1186/s12978-023-01727-4.
Cagnacci A, Gazzo I, Stigliani S, Paoletti AM, Anserini P, Londero AP et al. Oxidative stress: the role of estrogen and progesterone. Journal of Clinical Medicine. 2023 Nov; 12(23): 7304. doi: 10.3390/jcm12237304.
Quinn KM, Cox AJ, Roberts L, Pennell EN, McKeating DR, Fisher JJ et al. Temporal changes in blood oxidative stress biomarkers across the menstrual cycle and with oral contraceptive use in active women. European Journal of Applied Physiology. 2021 Sep; 121(9): 2607-20. doi: 10.1007/s00421-021-04734-0.
Drejza MA, Rylewicz K, Majcherek E, Gross-Tyrkin K, Mizgier M, Plagens-Rotman K et al. Markers of oxidative stress in obstetrics and Gynaecology-a systematic literature review. Antioxidants. 2022 Jul; 11(8): 1477. doi: 10.3390/antiox11081477.
Hashemi SJ, Khezri R, Saki N, Nasehi N, Hosseini SA, Harizi M et al. Association between oral contraceptives with lipid profile: results from Hoveyzeh cohort study (HCS). BioMed Central Women's Health. 2023 Oct; 23(1): 552. doi: 10.1186/s12905-023-02703-7.
Zhang T, Geng M, Li X, Gu Y, Zhao W, Ning Q et al. Identification of Oxidative Stress-Related Biomarkers for Pain-Depression Comorbidity Based on Bioinformatics. International Journal of Molecular Sciences. 2024 Jul; 25(15): 8353. doi: 10.3390/ijms25158353.
Santander N, Figueroa EG, González-Candia A, Maliqueo M, Echiburú B, Crisosto N et al. Oxidative stress in Polycystic ovary syndrome: impact of Combined Oral contraceptives. Antioxidants. 2024 Sep; 13(10): 1168. doi: 10.3390/antiox13101168.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
